By Christy Santhosh July 24 (Reuters) - Merck said on Friday it signed seven voluntary licensing agreements with generic drug ...

Following in the footsteps of Gilead Sciences, Merck & Co. has signed voluntary licensing agreements to enable access to its ...

Leaders at San Francisco's largest HIV clinic were blindsided when they learned federal officials cut off access to millions ...

Community-based groups that provide HIV testing and prevention tools are pushing federal health officials to renew a crucial ...

The health agency will route HIV prevention grants through state and local health departments instead of directly funding ...

A new report says the Trump administration’s disruptions to a global AIDS relief program have forced organizations to close ...

Millions of HIV/AIDS patients, many of them in Africa, face an uncertain future as a financial cliff-edge for US-funded global programs fast approaches.

By Jennifer Rigby and Vincent Mumo Nzilani LONDON/NAIROBI, July 21 (Reuters) - Around 77,000 fewer children worldwide received HIV treatment supported by the U.S. in the year to October 2025 than in ...

The Trump administration’s decision to redirect federal HIV prevention funding from community organizations to state and local health departments could disrupt testing, outreach and treatment services ...

Gilead Sciences and Merck said on Tuesday their experimental once-weekly HIV pill kept the virus suppressed in two late-stage trials, ​supporting regulatory filings for what could become the first ...

At least 78 children in Sindh, Pakistan, have been infected with HIV amid allegations of unsafe injection practices. Samaan Lateef reports.